Search 

We will give you all the power you need to run your partnering, investment and funding activities backed up by our experienced valuation team, solid and proven valuation tool. Xplico Evaluator is an easy-to-use, flexible MS Excel-based valuation tool with integrated risk assessment and powerful analysis features for the life science industry.

Our Biotech package includes valuation tool, training and valuation support for a low fixed monthly fee. 

We will be able to support you with latest market and benchmark data, build and review business cases and step in if you are short of resources. 

We can evaluate your projects and/or company for a fixed competitive fee or support you during partnering negotiations.

Xplico was established in 2005 with the purpose of develop and market an easy-to-use and standardized tool for valuation of project and portfolio in the life science industry. Xplico is today the market leader in valuation supporting more than 75 life science companies in Europe and US on a day to day basis

Our team today has unique extensive experience in valuation, forecasting and project/portfolio management, as well as in-depth knowledge of business processes in the life science industry, information technology and financial systems.

 Zaltanpharma is an Innovative pharmaceutical company

We are focus on specialist & hospital products

We offer:

 - Experience and proven sales results

- Support of icon Group, leading service company in the healthcare industry

- Presence in Europe and America

We are interested in:

 Prescription drugs to be promoted in our expertise areas:

- Cardiology

- Rheumatology

- Traumatology

- Psychiatry

- Neurology

- Pain/Musculoskeletal

- Gyneacology

- Urology

We are interested in MA to be launched, mature products and products to be acquired.

We are NOT interested in:

 Generics without any innovation in formulation or dosis

Food supplements

Nutraceuticals

Natural/homeopatic products

Branded products earlier than Phase III